XTX Topco Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$473,077
+32.8%
407,825
+72.8%
0.08%
+13.3%
Q1 2023$356,321
-58.9%
235,974
-32.0%
0.08%
-59.2%
Q4 2022$867,593
+153.7%
347,037
+327.8%
0.18%
+116.5%
Q3 2022$342,000
+56.9%
81,123
+3.9%
0.08%
-4.5%
Q2 2022$218,000
+86.3%
78,084
+282.1%
0.09%
+74.5%
Q1 2022$117,000
-59.2%
20,436
-23.8%
0.05%
-46.9%
Q3 2021$287,000
+49.5%
26,811
+125.8%
0.10%
+3.2%
Q1 2021$192,00011,8720.09%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders